Firefinch Ltd cashed up with A$100 million to execute aggressive growth plans
The company considers the significantly oversubscribed placement as a strong endorsement of its corporate strategy and the underlying quality...
Stay updated with breaking news from Morila Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company considers the significantly oversubscribed placement as a strong endorsement of its corporate strategy and the underlying quality...
"We are very pleased with progress at our Morila operations, which continue to advance towards our goal of achieving more than 100,000 ounces...
Extension and infill drilling at the Morila Super Pit will begin in June 2021 with the aim of improving the grade, confidence and size of resources and...
S&P/ASX 200 on track for seventh consecutive month of gains Amazon on Thursday released first-quarter results that exceeded analysts’ expectations, with sales soaring 44% year-over-year to US$108.5 billion and profits more than tripling to US$8.1 billion. Brent crude oil price rose 1.3% to US$68.16 a barrel on Thursday. S&P/ASX 200 (INDEXASX:XJO) dipped 0.60% to 7,039.5 points by 12.51 pm even as US markets rose overnight on strong corporate earnings data. Locally, this is a second weekly decline a row, but the ASX 200 remains firmer for the month with a gain of 3.6%. This would...
FTSE 100 closes on the front foot, with AstraZeneca the top riser Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969, FTSE 100 closes around eight points higher AstraZeneca top blue-chip riser 5.05pm: FTSE closes ahead FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog. Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view. Over the week as a whole , the FTSE 100 added ar...